Login to Your Account



Amgen Gets Even Stronger With $1.3B Tularik Acquisition

By Karen Pihl-Carey


Tuesday, March 30, 2004
In one of the largest biotech deals this year, Amgen Inc. caught the big fish, so to speak, by reeling in Tularik Inc. with a $1.3 billion takeover bid. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription